Legorreta Pablo G. (CIK 1507678) reported 9 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy RPRX (65,216 shares), Buy RPRX (143,821 shares), Buy RPRX (157,828 shares), Buy RPRX (36,559 shares), Buy RPRX (21,901 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 65,216 | $0 |
| 2026-05-08 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 143,821 | $0 |
| 2026-02-13 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 157,828 | $0 |
| 2025-11-07 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 36,559 | $0 |
| 2025-08-08 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 21,901 | $0 |
| 2025-06-05 | PROKIDNEY CORP. (PROK) | Director | Buy | 3.8M | $0 |
| 2025-06-05 | PROKIDNEY CORP. (PROK) | Director | Sell | 3.8M | $0 |
| 2025-05-20 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 530,348 | $0 |
| 2025-05-09 | Royalty Pharma plc (RPRX) | CEO, Chairman of the Board | Buy | 288,352 | $0 |
Source: SEC Form 4 filings · as of 2026-08-07